Could a nasal spray help kids with autism? new trial begins

NCT ID NCT07243561

Recruiting now Disease control Sponsor: Dongfang People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This early-stage trial is testing whether a nasal spray made from stem cell exosomes can safely improve core symptoms in 40 children aged 3-7 with autism. Half the children get the spray every other day for 10 doses, while the other half receive no treatment. Researchers will track side effects and changes in autism severity over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: human umbilical cord mesenchymal stem cell-derived exosomes (hUC-MSC-EXOs) nasal spray
What this could lead to: If it works, this could point toward a new way to ease core autism symptoms in children using a simple nasal spray.
What could go wrong: This is an early Phase 1/2 trial with only 40 children, so results may not apply broadly. The treatment is experimental and safety is still being checked.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER (ASD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER (ASD PROSPECTIVE STUDY

Contacts and locations

Locations

Dongfang People's Hospital
RECRUITING

Dongfang, Hainan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.